Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, (Adjuvanted With MF59C.1) Influenza Vaccine, Formulation 2005-2006, When Administered to Elderly Subjects.

NCT00316628 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00316628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, (Adjuvanted With MF59C.1) Influenza Vaccine, Formulation 2005-2006, When Administered to Elderly Subjects.
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
50
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza